The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Studies of the molecular mechanisms in the regulation of telomerase activity
Abstract
Telomerase, a specialized RNA‐directed DNA polymerase that extends telomeres of eukaryotic chromosomes, is repressed in normal human somatic cells but is activated during development and upon neoplasia. Whereas activation is involved in immortalization of neoplastic cells, repression of telomerase permits consecutive shortening of telomeres in a chromosome replication‐dependent fashion. This cell cycle‐dependent, unidirectional catabolism of telomeres constitutes a mechanism for cells to record the extent of DNA loss and cell division number; when telomeres become critically short, the cells terminate chromosome replication and enter cellular senescence. Although neither the telomere signaling mechanisms nor the mechanisms whereby telomerase is repressed in normal cells and activated in neoplastic cells have been established, inhibition of telomerase has been shown to compromise the growth of cancer cells in culture; conversely, forced expression of the enzyme in senescent human cells extends their life span to one typical of young cells. Thus, to switch telomerase on and off has potentially important implications in anti‐aging and anti‐cancer therapy. There is abundant evidence that the regulation of telomerase is multifactorial in mammalian cells, involving telomerase gene expression, post‐translational protein‐protein interactions, and protein phosphorylation. Several protooncogenes and tumor suppressor genes have been implicated in the regulation of telomerase activity, both directly and indirectly; these include c‐Myc, Bcl‐2, p21 WAF1 , Rb, p53, PKC, Akt/PKB, and protein phosphatase 2A. These findings are evidence for the complexity of telomerase control mechanisms and constitute a point of departure for piecing together an integrated picture of telomerase structure, function, and regulation in aging and tumor development—Liu, J.‐P. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 13, 2091–2104 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 2×
“Telomeres are primarily controlled by a highly specialized DNA polymerase, termed telomerase, which is activated in most human cancers and immortal cell lines (16, 17); the mechanisms of activation and regulation of telomerase, however, have yet to be established.”
BackgroundTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“Telomerase is a large ribonucleoprotein complex (56, 57) containing an RNA subunit (58–63) and several protein components.”
BackgroundA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 2×
“Telomeres are primarily controlled by a highly specialized DNA polymerase, termed telomerase, which is activated in most human cancers and immortal cell lines (16, 17); the mechanisms of activation and regulation of telomerase, however, have yet to be established.”
BackgroundMammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 1×
“Recent studies with electron microscopy have revealed that TRF2 remodels linear telomeric DNA into large duplex loops (t loops) in vitro (31).”
BackgroundTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Cited by
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605
Perturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
Pathogenesis of Human Papillomaviruses in Differentiating Epithelia
Longworth, M. S., & Laimins, L. A. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.362-372.2004 · Cited by 677
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132738 · Cited by 630
Haendeler, J., Hoffmann, J., Diehl, J. F., Vasa, M., Spyridopoulos, I., Zeiher, A. M., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000121104.05977.f3 · Cited by 384
Nitric Oxide Activates Telomerase and Delays Endothelial Cell Senescence
Vasa, M., Breitschopf, K., Zeiher, A. M., & Dimmeler, S. (2000) · Circulation Research · doi:10.1161/01.res.87.7.540 · Cited by 314
Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation
Fehrmann, F., & Laimins, L. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206554 · Cited by 292
Haendeler, J., Hoffmann, J., Brandes, R. P., Zeiher, A. M., & Dimmeler, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4598-4610.2003 · Cited by 268
Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F. T., & Benhattar, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10593 · Cited by 260
Oh, S. T., Kyo, S., & Laimins, L. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5559-5566.2001 · Cited by 201
The Catalytic Subunit of Telomerase Protects Neurons Against Amyloid β‐Peptide‐Induced Apoptosis
Zhu, H., Fu, W., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750117.x · Cited by 175
Zhang, T.-C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg141 · Cited by 142
The role of telomeres in the ageing of human skin: Telomeres and skin ageing
Buckingham, E. M., & Klingelhutz, A. J. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01242.x · Cited by 109
Transcriptional regulation of telomerase activity: Roles of the the Ets transcription factor family
DWYER, J., LI, H., XU, D., & LIU, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.022 · Cited by 77
Self-citationRecent Patents on Anti-Telomerase Cancer Therapy
Agrawal, A., Dang, S., & Gabrani, R. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489212798357958 · Cited by 61
Telomeres, a busy platform for cell signaling.
Gardano, L., Pucci, F., Christian, L., Le Bihan, T., & Harrington, L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00146 · Cited by 15
“Taken together, these results indicate that the distribution of β-catenin differed between the two cell types. β-Catenin is a target of the GSK3β kinase which phosphorylates the residues S33/37, and T41.”
BackgroundInfluential
Metadata
- Authors
- LIU, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 13
- Issue
- 15
- Pages
- 2091-2104
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1947454248
- Cited by
- 254
- References
- 177
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.